The FDA has issued a drug safety communication updating the public

The FDA has issued a drug safety communication updating the public about new labeling information which has been added to the physician labeling and patient labeling (Medication Guide) on the cardiovascular risks (including heart attack) of the drug Avandia (rosiglitazone). For more information, please click here.

AACE
Guidelines

AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources

AACE
Publications

AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.